Correlation Between Network18 Media and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Network18 Media and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Network18 Media and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Network18 Media Investments and Beta Drugs, you can compare the effects of market volatilities on Network18 Media and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Network18 Media with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Network18 Media and Beta Drugs.

Diversification Opportunities for Network18 Media and Beta Drugs

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Network18 and Beta is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Network18 Media Investments and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Network18 Media is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Network18 Media Investments are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Network18 Media i.e., Network18 Media and Beta Drugs go up and down completely randomly.

Pair Corralation between Network18 Media and Beta Drugs

Assuming the 90 days trading horizon Network18 Media is expected to generate 4.12 times less return on investment than Beta Drugs. In addition to that, Network18 Media is 1.08 times more volatile than Beta Drugs. It trades about 0.02 of its total potential returns per unit of risk. Beta Drugs is currently generating about 0.09 per unit of volatility. If you would invest  71,100  in Beta Drugs on September 2, 2024 and sell it today you would earn a total of  146,085  from holding Beta Drugs or generate 205.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.39%
ValuesDaily Returns

Network18 Media Investments  vs.  Beta Drugs

 Performance 
       Timeline  
Network18 Media Inve 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Network18 Media Investments has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Beta Drugs 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Network18 Media and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Network18 Media and Beta Drugs

The main advantage of trading using opposite Network18 Media and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Network18 Media position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Network18 Media Investments and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios